Mounjaro, a innovative drug from a pharmaceutical firm , is sparking significant buzz within the diabetes field . This subcutaneous medication works in a distinct way, impacting several receptors involved in blood regulation : GIP and GLP-1. Early studies suggest it may provide substantial improvements in blood sugar levels , conceivably even be… Read More